Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

ARVs [antiretrovirals] to Prevent Breastmilk HIV:Viral and Immune Responses

Trial Profile

ARVs [antiretrovirals] to Prevent Breastmilk HIV:Viral and Immune Responses

Phase of Trial: Phase II

Latest Information Update: 01 Apr 2017

At a glance

  • Drugs Lamivudine (Primary) ; Nevirapine (Primary) ; Zidovudine (Primary)
  • Indications HIV-1 infections
  • Focus Therapeutic Use
  • Most Recent Events

    • 31 Aug 2018 Biomarkers information updated
    • 15 Aug 2009 Results published in the Journal of Acquired Immune Deficiency Syndromes.
    • 20 Nov 2007 Status changed from in progress to completed.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top